Paul Gerard Levesque

RN, NP | Nurse Practitioner

Paul Gerard Levesque is a Concord, Massachusetts based nurse practitioner. His current practice location is 696 Virginia Rd, Concord. Patients can reach him at 978-318-8952 or can fax him at 978-318-9789. Paul Gerard Levesque is RN, NP and his NPI number (Unique professional ID assigned by NPPES) is 1992860761.
Paul Gerard Levesque has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.

Complete Profile:
Paul Gerard Levesque speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Paul Gerard Levesque
Specialization: Nurse Practitioner (NP)
Gender:Male
Credentials: RN, NP
Practice Address:696 Virginia Rd, Concord,
Massachusetts, 01742-2718
Phone:978-318-8952
Fax:978-318-9789
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1992860761
NPI Enumeration Date: 22 Dec, 2006
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Paul Gerard Levesque
696 Virginia Rd,
Concord, Massachusetts
Zip: 01742-2718
Phone Number: 978-318-8952
Fax Number: 978-318-9789
Patients can reach Paul Gerard Levesque at 696 Virginia Rd, Concord, Massachusetts or can call to book an appointment on 978-318-8952.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.